In the literature, CD64 expression in APL is frequently reported, with intermediate mean fluorescence intensities (MFIs), whereas the relatively lower range of MFIs observed in our cohort may be attributed to set thresholds [35,36]. The gene discussed is FCGR1A; the disease is acute promyelocytic leukemia.